Conducting Clinical Trials With Decentralized Elements
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 18, 2024
September 18, 2024
dc054f22-ff9d-4ea3-8083-fe59c7622408
Related Documents
Cancer Clinical Trial Eligibility Criteria: Laboratory Values: Guidance for Industry, IRBs, and Clinical Investigators
Guidance DocumentJuly 27, 2026Office of the Commissioner
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance DocumentMay 26, 2023Center for Drug Evaluation and Research
Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Guidance DocumentDecember 22, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.